ESC 365 - ESCAPE - Effect of alirocumab on the frequency of lipoprotein apheresis: a randomised Phase III trial

Back

ESC Premium Access

ESCAPE - Effect of alirocumab on the frequency of lipoprotein apheresis: a randomised Phase III trial

Session: Hot Line prevention and lipids

Topic: Lipids

Speaker: Doctor P. Moriarty (Kansas City, US)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Patrick Moriarty

University of Kansas Medical Center, Kansas City (United States of America)

2 presentations

0 follower

14 more presentations in this session

HIJ-PROPER - LDL cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidemia

Speaker: Professor N. Hagiwara (Tokyo, JP)

Access

Slides

Video

HIJ-PROPER - Discussant review.

Speaker: Professor S. Gielen (Detmold, DE)

Access

Slides

Video

HIJ-PROPER - Panel discussion.

Access

Video

OPTICARE - Benefits of the OPTImal CArdiac REhabilitation trial: a randomized, controlled superiority trial of an expanded educational and behavioral intervention

Speaker: Doctor R. Van Domburg (Rotterdam, NL)

OPTICARE - Discussant review.

Speaker: Professor A. Abreu (Lisbon, PT)

Access

Slides

Video

Access the full session

Hot Line prevention and lipids

Speakers: Doctor P. Moriarty, Professor N. Hagiwara, Professor S. Gielen, Doctor R. Van Domburg, Professor A. Abreu

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources